BofAS maintains a Neutral rating on STANCHART due to the company's new medium-term targets, which align with market expectations. While there is potential for revenue growth and improved cost efficiency, concerns about increased capital requirements for growth may slow overall return on equity. The target price has been raised from HKD 209.8 to HKD 227 based on upward revisions to earnings forecasts.
